These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35931717)
1. Specific gut microbiota alterations in essential tremor and its difference from Parkinson's disease. Zhang P; Huang P; Du J; He Y; Liu J; He G; Cui S; Zhang W; Li G; Chen S NPJ Parkinsons Dis; 2022 Aug; 8(1):98. PubMed ID: 35931717 [TBL] [Abstract][Full Text] [Related]
2. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424 [TBL] [Abstract][Full Text] [Related]
3. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease. Huang P; Zhang P; Du J; Gao C; Liu J; Tan Y; Chen S NPJ Parkinsons Dis; 2023 Jul; 9(1):115. PubMed ID: 37460569 [TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease. Ren T; Gao Y; Qiu Y; Jiang S; Zhang Q; Zhang J; Wang L; Zhang Y; Wang L; Nie K Front Neurol; 2020; 11():137. PubMed ID: 32161568 [No Abstract] [Full Text] [Related]
5. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131 [TBL] [Abstract][Full Text] [Related]
6. The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors. Wu Z; Zhang S; Li L; Huang Z; Huang D; Hu Y Front Oncol; 2022; 12():887383. PubMed ID: 36387171 [TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Gut Dysbiosis in Parkinson's Disease. Nishiwaki H; Ito M; Ishida T; Hamaguchi T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K Mov Disord; 2020 Sep; 35(9):1626-1635. PubMed ID: 32557853 [TBL] [Abstract][Full Text] [Related]
8. [Features of gut microbiota in patients with idiopathic Parkinson's disease]. Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860 [No Abstract] [Full Text] [Related]
9. An analysis of the characteristics of the intestinal flora in patients with Parkinson's disease complicated with constipation. Chen W; Bi Z; Zhu Q; Gao H; Fan Y; Zhang C; Liu X; Ye M Am J Transl Res; 2021; 13(12):13710-13722. PubMed ID: 35035709 [TBL] [Abstract][Full Text] [Related]
10. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia. Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706 [TBL] [Abstract][Full Text] [Related]
11. Dysbiosis of gut microbiota in patients with esophageal cancer. Deng Y; Tang D; Hou P; Shen W; Li H; Wang T; Liu R Microb Pathog; 2021 Jan; 150():104709. PubMed ID: 33378710 [TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030 [TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of gut microbiota in a selected population of Parkinson's patients. Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953 [TBL] [Abstract][Full Text] [Related]
15. Alterations of gut microbiota and metabolome with Parkinson's disease. Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073 [TBL] [Abstract][Full Text] [Related]
16. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385 [TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Electrophysiological Biomarkers of Parkinson's Disease Developed From Essential Tremor. Wang X; Cao Z; Liu G; Liu Z; Jiang Y; Ma H; Wang Z; Yang Y; Chen H; Feng T Front Neurol; 2020; 11():582471. PubMed ID: 33193041 [No Abstract] [Full Text] [Related]
18. Depression and social phobia in essential tremor and Parkinson's disease. Smeltere L; Kuzņecovs V; Erts R Brain Behav; 2017 Sep; 7(9):e00781. PubMed ID: 28948077 [TBL] [Abstract][Full Text] [Related]
19. Oral, Nasal, and Gut Microbiota in Parkinson's Disease. Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538 [TBL] [Abstract][Full Text] [Related]
20. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing. Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]